Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Mellow, Carlos Solano-Lopez, Sue Davis (1993)
Sodium Valproate in the Treatment of Behavioral Disturbance in DementiaJournal of Geriatric Psychiatry and Neurology, 6
J. Wilcox (1994)
Divalproex sodium in the treatment of aggressive behavior.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 6 1
M. Freeman, A. Stoll (1998)
Mood stabilizer combinations: a review of safety and efficacy.The American journal of psychiatry, 155 1
S. Donovan, E. Susser, Edward Nunes, Jonathan Stewart, F. Quitkin, D. Klein (1997)
Divalproex treatment of disruptive adolescents: a report of 10 cases.The Journal of clinical psychiatry, 58 1
M. Linnoila, M. Viukari, O. Hietala (1976)
Effect of Sodium Valproate on Tardive DyskinesiaBritish Journal of Psychiatry, 129
Jeffrey Mattes (1992)
Valproic acid for nonaffective aggression in the mentally retarded.The Journal of nervous and mental disease, 180 9
S. McElroy, P. Keck, H. Pope, J. Hudson (1989)
Sensitization, kindling, and anticonvulsants in mania.The Journal of Clinical Psychiatry, 50
B. Wilder, B. Karas, Penry Jk, J. Asconapé (1983)
Gastrointestinal tolerance of divalproex sodiumNeurology, 33
(1998)
Depakote and Depakene product information in Physicians' Desk Reference, 52nd Edition
Schaff Mr, Jan Fawcett, J. Zajecka (1993)
Divalproex sodium in the treatment of refractory affective disorders.The Journal of clinical psychiatry, 54 10
Leslie Citrome, Jerome Levine, B. Allingham (1996)
Utilization of depot neuroleptic medication in psychiatric inpatients.Psychopharmacology bulletin, 32 3
P. Roy-Byrne, N. Ward, P. Donnelly (1989)
Valproate in anxiety and withdrawal syndromes.The Journal of clinical psychiatry, 50 Suppl
B. Wroblewski, A. Joseph, J. Kupfer, K. Kalliel (1997)
Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury.Brain injury, 11 1
J. Wilcox (1995)
Divalproex sodium as a treatment for borderline personality disorder.Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 7 1
D. Stein, D. Simeon, M. Frenkel, M. Islam, E. Hollander (1995)
An open trial of valproate in borderline personality disorder.The Journal of clinical psychiatry, 56 11
S. McElroy, P. Keck, H. Pope, J. Hudson (1989)
Valproate in psychiatric disorders: literature review and clinical guidelines.The Journal of clinical psychiatry, 50 Suppl
(1987)
The effect of sodium valproate on tardive dyskinesiarevisited
M. Sheard, J. Marini, C. Bridges, E. Wagner (1976)
The effect of lithium on impulsive aggressive behavior in man.The American journal of psychiatry, 133 12
S. McElroy, P. Keck, H. Pope (1987)
Sodium valproate: its use in primary psychiatric disorders.Journal of clinical psychopharmacology, 7 1
(1998)
Depakote and Depakene product information in Physicians' Desk Reference
L. Citrome (1995)
Use of Lithium, Carbamazepine, and Valproic Acid in a State-Operated Psychiatric HospitalJournal of Pharmacy Technology, 11
T. Kastner, Debra Friedman, Alice Plummer, Marilyn Ruiz, Dana Henning (1990)
Valproic acid for the treatment of children with mental retardation and mood symptomatology.Pediatrics, 86 3
J Levine, L Citrome, B Allingham (1997)
An effectiveness study comparing oral and depot neuroleptic medicationsPsychopharmacology Bulletin, 33
P. Keck, S. McElroy, L. Friedman (1992)
Valproate and Carbamazepine in the Treatment of Panic and Posttraumatic Stress Disorders, Withdrawal States, and Behavioral Dyscontrol SyndromesJournal of Clinical Psychopharmacology, 12
Angel Moriñigo, J. Martı́n, S. González, I. Mateo (1989)
Treatment of resistant schizophrenia with valproate and neuroleptic drugs.The Hillside journal of clinical psychiatry, 11 2
F. Primeau, R. Fontaine, L. Beauclair (1990)
Valproic Acid and Panic Disorder *The Canadian Journal of Psychiatry, 35
G. Fisk, S. York (1987)
The Effect of Sodium Valproate on Tardive Dyskinesia - RevisitedBritish Journal of Psychiatry, 150
B. Wilder, B. Karas, E. Hammond, R. Perchalski (1983)
Twice‐daily dosing of valproate with divalproexClinical Pharmacology & Therapeutics, 34
Lott Ad, Susan McElroy, Keys Ma (1995)
Valproate in the treatment of behavioral agitation in elderly patients with dementia.The Journal of neuropsychiatry and clinical neurosciences, 7 3
C. Bowden, A. Brugger, A. Swann, J. Calabrese, P. Janicak, F. Petty, S. Dilsaver, John Davis, A. Rush, J. Small (1994)
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.JAMA, 271 12
R. Gerner, Abigail Stanton (1992)
Algorithm for Patient Management of Acute Manic States: Lithium, Valproate, or Carbamazepine?Journal of Clinical Psychopharmacology, 12
G. Heninger, D. Charney, D. Sternberg (1983)
Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.Archives of general psychiatry, 40 12
(1997)
The use of divalproex
G. Heninger, D. Charney, D. Sternberg (1984)
Lithium carbonate augmentation of antidepressant treatmentJournal of Clinical Psychopharmacology, 4
P. Keck, S. McElroy, S. Strakowski (1996)
New developments in the pharmacologic treatment of schizoaffective disorder.The Journal of clinical psychiatry, 57 Suppl 9
C. Mazure, B. Druss, J. Cellar (1992)
Valproate Treatment of Older Psychotic Patients with Organic Mental Syndromes and Behavioral DyscontrolJournal of the American Geriatrics Society, 40
Scott Haas, K. Vincent, J. Holt, S. Lippmann (1997)
Divalproex: A Possible Treatment Alternative for Demented, Elderly Aggressive PatientsAnnals of Clinical Psychiatry, 9
(1997)
An effectiveness study comparing oral a n d d e p o t n e u r o l e p t i c m e d i c a t i o n s . B u l l e t i n 3 3
Theodore Kastner, Ross FineSmith, K. Walsh (1993)
Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation.Journal of clinical psychopharmacology, 13 6
D. Kahn, E. Stevenson, C. Douglas (1988)
Effect of sodium valproate in three patients with organic brain syndromes.The American journal of psychiatry, 145 8
(1995)
Effectiveness of divalproex sodium, valproic acid and carbamazepine in aggression (poster)
James Chou (1991)
Recent advances in treatment of acute mania.Journal of clinical psychopharmacology, 11 1
Luchins Dj (1984)
Carbamazepine in violent non-epileptic schizophrenics.Psychopharmacology Bulletin, 20
C. Bowden, A. Brugger, A. Swann, J. Calabrese, P. Janicak, F. Petty, S. Dilsaver, John Davis, A. Rush, J. Small, E. Garza-Treviño, S. Risch, P. Goodnick, D. Morris, V. Shu, P. Johnson, M. Blake, M. Javors, L. Ereshefsky, T. McLeod, A. Shoaib, Mark Johnson, S. Kimmel, A. Wesley, R. Qualtiere, C. Trivedi, J. Javaid, J. Peterson, M. Lambert, M. Zielinski, P. Orsulak, L. Sharp, L. Akers, M. Miller, J. Kellams, G. Woodham, A. Frazer (1994)
Efficacy of Divalproex vs Lithium and Placebo in the Treatment of ManiaJAMA, 271
A. Wassef, D. Watson, P. Morrison, S. Bryant, J. Flack (1989)
Neuroleptic-valproic acid combination in treatment of psychotic symptoms: a three-case report.Journal of clinical psychopharmacology, 9 1
B. Shah, H. Ratner (1993)
Anti-convulsant drugs, smoking, and body weights in psychiatric in-patients.New York state journal of medicine, 93 1
GR Heninger, DS Charney, DE Sternberg (1983)
Lithium carbonate augmentation of antidepressant treatmentArchives General Psychiatry, 40
Objective: To describe the extent and type of use of valproate among hospitalized psychiatric patients. Method: A database containing patient information and drug prescription information for every in-patient within the adult civil facilities of the New York State Office of Mental Health was queried. Results: In 1994, 2,888 of 18,668 in-patients received valproate (15.5%). In 1996, 4,247 of 12,444 in-patients received valproate (34.1%). In 1996, approximately 50% of all patients diagnosed as bipolar or schizoaffective, and 28% of all patients diagnosed with schizophrenia, received valproate. Once started on valproate, over 90% remained on it after 2 weeks, with no difference found in the discontinuation rates between valproic acid or divalproex sodium at the end of the initial 14 day period. Patients received valproate for approximately two-thirds of their hospital stay, at a mean dose of 1400 mg/day. 95% also received concomitant antipsychotics, and 20% received concomitant lithium. Use of lithium and carbamazepine was less in 1996 than in 1994, but the magnitude of this change was much less than the increase in utilization of valproate. Conclusions: From 1994 to 1996 valproate use has more than doubled, and it is being used widely in patients with schizophrenia, an off-label indication for which there is only anecdotal support in the literature. Given the lack of difference in early discontinuation rates, there are probably no dramatic differences in side effects for the two preparations of valproate.
Psychiatric Quarterly – Springer Journals
Published: Oct 6, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.